Understanding Zovirax
Zovirax 200mg is a synthetic nucleoside analogue extensively investigated for its antiviral properties in laboratory research. Developed by GlaxoSmithKline, this compound contains acyclovir as its active pharmaceutical ingredient, offering researchers a well-characterised tool for studying viral replication mechanisms and nucleoside analogue interactions. The pharmaceutical-grade formulation provides consistent compound delivery for in-vitro investigations examining herpes simplex virus inhibition pathways. Laboratory studies have demonstrated its selective targeting of viral thymidine kinase, making it an invaluable research tool for understanding antiviral resistance mechanisms and viral DNA polymerase function. Researchers investigating nucleoside analogues can access this compound alongside other research chemicals available through Stroid UK Shop, a leading UK supplier of laboratory-grade compounds.
Laboratory Applications
In research settings, scientists study Zovirax 200mg to examine viral DNA synthesis inhibition and nucleoside incorporation mechanisms. The compound serves as a reference standard in antiviral research, allowing investigators to evaluate comparative efficacy of novel antiviral candidates. Cell culture studies utilise this compound to examine viral replication cycles and identify critical intervention points in herpes virus lifecycle. Researchers exploring antiviral resistance frequently investigate this compound alongside studies available in our antiviral compounds category. Additionally, pharmacokinetic studies examine absorption, distribution, and elimination pathways using this well-characterised nucleoside analogue. The compound’s selective targeting mechanisms make it particularly valuable for studying viral enzyme specificity compared to host cell enzymes. Research applications extend to investigating combination therapies and synergistic effects with other antiviral agents. Scientists also examine resistance mutation patterns and their impact on compound efficacy in laboratory models. Studies investigating nucleoside transport mechanisms and cellular uptake pathways benefit from this compound’s established pharmacological profile. Researchers can complement these antiviral studies with compounds from our SARMs collection or explore peptide-based research through our peptides range for comprehensive molecular research programmes.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Acyclovir |
| Strength | 200mg per tablet |
| Manufacturer | GlaxoSmithKline |
| Form | Oral tablet |
| CAS Number | 59277-89-3 |
| Molecular Formula | C₈H₁₁N₅O₃ |
| Molecular Weight | 225.21 g/mol |
| Storage Requirements | Room temperature, dry conditions |
Research Compliance Statement
This Zovirax 200mg formulation is supplied strictly for in-vitro laboratory research applications only. The compound is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must ensure proper laboratory protocols and safety measures when handling this material. All studies should comply with institutional research guidelines and applicable regulatory frameworks governing laboratory chemical use. This product is designed exclusively for qualified research professionals conducting legitimate scientific investigations in controlled laboratory environments.
